Skip to content
Pharma Observatory a Scientist.com platform
  • Trial site

Trial site location from the registry's own city and country. GeoNames (geonames.org).

Clinical trial site

Samsung Medical Center

Samsung Medical Center in Seoul, South Korea is listed as a site for 2,071 registered clinical trials, 609 of them ongoing.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Registered trials 2,071
Ongoing 609

This page covers the site record Samsung Medical Center in Seoul, South Korea: the trials that list it by this name in ClinicalTrials.gov. The same place can be registered under other names, each with its own page and its own trials, and a count here is a number of registered trials, not of patients enrolled. The organization of the same name, Samsung Medical Center, also sponsors trials.

Get the Samsung Medical Center report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Trials by phase

Registered trials that list this site, by trial phase. 2,071 trials counted.

  • Phase 1 181 trials
  • Phase 1/2 147 trials
  • Phase 2 380 trials
  • Phase 2/3 36 trials
  • Phase 3 596 trials
  • Phase 4 112 trials
  • Not applicable 292 trials
  • Observational 325 trials
  • Expanded access 2 trials

Trials by status

The registry's own status summary: Ongoing, Completed, Terminated or Other.

  • Ongoing 609 trials
  • Completed 974 trials
  • Terminated 210 trials
  • Other 278 trials

Trials over time

Trials registered with a start date in each year, 1990 onward, most recent years first.

Trials over time, by phase

  • Phase 1
  • Phase 1/2
  • Phase 2
  • Phase 2/3
  • Phase 3
  • Phase 4
  • Not applicable
  • Observational

Top of scale: 173

1994: 1 trials (Observational 1) 1996: 1 trials (Observational 1) 1998: 1 trials (Phase 2 1) 1999: 1 trials (Phase 3 1) 2003: 2 trials (Not applicable 1, Phase 3 1) 2004: 6 trials (Observational 2, Not applicable 1, Phase 3 1, Phase 2/3 1, Phase 1 1) 2005: 13 trials (Observational 2, Not applicable 1, Phase 4 3, Phase 3 4, Phase 2 2, Phase 1 1) 2006: 19 trials (Observational 4, Not applicable 2, Phase 4 5, Phase 3 2, Phase 2 4, Phase 1/2 2) 2007: 25 trials (Observational 2, Not applicable 7, Phase 4 5, Phase 3 6, Phase 2 4, Phase 1 1) 2008: 58 trials (Observational 11, Not applicable 6, Phase 4 5, Phase 3 13, Phase 2 19, Phase 1/2 2, Phase 1 2) 2009: 49 trials (Observational 8, Not applicable 8, Phase 4 8, Phase 3 12, Phase 2/3 2, Phase 2 8, Phase 1 3) 2010: 69 trials (Observational 16, Not applicable 7, Phase 4 7, Phase 3 15, Phase 2/3 2, Phase 2 13, Phase 1/2 3, Phase 1 6) 2011: 70 trials (Observational 19, Not applicable 7, Phase 4 9, Phase 3 9, Phase 2/3 2, Phase 2 15, Phase 1 9) 2012: 87 trials (Observational 20, Not applicable 14, Phase 4 10, Phase 3 21, Phase 2/3 2, Phase 2 9, Phase 1/2 2, Phase 1 9) 2013: 88 trials (Observational 13, Not applicable 10, Phase 4 6, Phase 3 30, Phase 2 16, Phase 1/2 3, Phase 1 10) 2014: 107 trials (Observational 25, Not applicable 17, Phase 4 7, Phase 3 20, Phase 2/3 2, Phase 2 20, Phase 1/2 7, Phase 1 9) 2015: 105 trials (Observational 19, Not applicable 9, Phase 4 5, Phase 3 35, Phase 2/3 1, Phase 2 23, Phase 1/2 5, Phase 1 8) 2016: 111 trials (Observational 25, Not applicable 16, Phase 4 4, Phase 3 33, Phase 2/3 1, Phase 2 21, Phase 1/2 4, Phase 1 7) 2017: 135 trials (Observational 24, Not applicable 27, Phase 4 5, Phase 3 35, Phase 2/3 1, Phase 2 23, Phase 1/2 7, Phase 1 13) 2018: 117 trials (Observational 17, Not applicable 15, Phase 4 2, Phase 3 36, Phase 2/3 3, Phase 2 20, Phase 1/2 14, Phase 1 10) 2019: 117 trials (Observational 18, Not applicable 17, Phase 4 4, Phase 3 32, Phase 2/3 5, Phase 2 21, Phase 1/2 14, Phase 1 6) 2020: 134 trials (Observational 9, Not applicable 21, Phase 4 6, Phase 3 43, Phase 2/3 2, Phase 2 27, Phase 1/2 14, Phase 1 12) 2021: 173 trials (Observational 17, Not applicable 28, Phase 4 5, Phase 3 56, Phase 2/3 2, Phase 2 33, Phase 1/2 15, Phase 1 17) 2022: 138 trials (Observational 21, Not applicable 19, Phase 4 3, Phase 3 45, Phase 2/3 3, Phase 2 20, Phase 1/2 13, Phase 1 14) 2023: 120 trials (Observational 14, Not applicable 12, Phase 4 1, Phase 3 39, Phase 2/3 1, Phase 2 25, Phase 1/2 13, Phase 1 15) 2024: 127 trials (Observational 12, Not applicable 16, Phase 4 2, Phase 3 43, Phase 2/3 1, Phase 2 23, Phase 1/2 14, Phase 1 16) 2025: 121 trials (Observational 14, Not applicable 17, Phase 4 5, Phase 3 43, Phase 2/3 3, Phase 2 20, Phase 1/2 9, Phase 1 10)

Trials that list this site and are registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table). The table below lists the same counts, most recent years first.

Trials started per year
Year Trials started
2026 (partial year) 70
2025 121
2024 127
2023 120
2022 138
2021 173
2020 134
2019 117
2018 117
2017 135

Showing 10 of 28 years.

Start your 14-day trial Email me all 28 years as a PDF

2026 is partial: trials registered with a 2026 start date so far, not a full year. 2 trials are registered to start in 2027 or later, and not listed here

Recent trials

The newest registered trials that list this site. Each title opens its ClinicalTrials.gov record.

Showing 5 of 2,071 trials.

Start your 14-day trial Email me the first 50 trials as a PDF

Source: ClinicalTrials.gov

Lead sponsors

Most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.

Showing 5 of 363 lead sponsors.

Start your 14-day trial Email me the first 50 lead sponsors as a PDF

Conditions studied

The specific conditions of the trials that list this site, most trials first.

Showing 5 of 531 conditions.

Start your 14-day trial Email me the first 50 conditions as a PDF